Clinical Trial Update: Toxicity/Benefit Ratio Optimization of Chemotherapy in Colorectal Cancer (CRC) Patients by Determination of Individual Genotypic Determinants [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining how individual genetic determinants can optimize the toxicity/benefit balance of chemotherapy in metastatic colorectal c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Institut de Recherche Clinique sur les Cancers et le Sang | Conditions: Metastatic Colorectal Cancer | Phase 4 | Status: COMPLETED